SCHEMBL352441

SCHEMBL352441

Cc1cccc(CCc2c(-c3ccc4c(C(N)=O)cccc4c3CCc3cccc(C)c3)ccc3c(C(N)=O)cccc23)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RPS6KB1 P23443 3/20 0.46
AURKA O14965 2/20 0.46
NR3C2 P08235 1/20 0.43
SIRT2 Q8IXJ6 1/20 0.43
ADRA1D P25100 1/20 0.43
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 2/20 0.42
HPGD P15428 2/20 0.42
HSD17B10 Q99714 1/20 0.42
TAAR1 Q96RJ0 2/20 0.42
MAPK8 P45983 1/20 0.42
PARP1 P09874 1/20 0.39
DAO P14920 1/20 0.39
CASP3 P42574 1/20 0.38
CASP7 P55210 1/20 0.38
CD38 P28907 1/20 0.38
AURKB Q96GD4 1/20 0.38
GPR84 Q9NQS5 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL353653 0.88 RPS6KB1 (0.46) RPS6KB1AURKANR3C2SIRT2ADRA1D
SCHEMBL353377 0.85 SIRT2 (0.47) RPS6KB1AURKASIRT2ADRA1DKDM4E
SCHEMBL355055 0.76 CD38 (0.39) RPS6KB1AURKAKDM4EALDH1A1PARP1
SCHEMBL634715 0.71 KMT2A (0.46) KDM4EALDH1A1HPGDHSD17B10PARP1
SCHEMBL352442 0.69 F2 (0.42) RPS6KB1AURKANR3C2SIRT2ADRA1D
SCHEMBL6135290 0.68 ATM (0.61) AURKAKDM4EALDH1A1HPGDHSD17B10
SCHEMBL8096473 0.68 TAAR1 (0.74) NR3C2TAAR1DAOGPR84
SCHEMBL29596752 0.68 TAAR1 (0.74) NR3C2TAAR1DAOGPR84
SCHEMBL4977141 0.68 KDM4E (0.49) RPS6KB1AURKANR3C2SIRT2ADRA1D
SCHEMBL3053513 0.68 TAAR1 (0.58) NR3C2KDM4EALDH1A1TAAR1PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2418942-A1 NAPHTHALENE-BASED INHIBITORS OF ANTI-APOPTOTIC PROTEINS Sanford-Burnham Medical Research Institute (US) 2012-02-22 EP disclosed
US-20120015992-A1 Napthalene-Based Inhibitors of Anti-Apoptotic Proteins BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2012-01-19 US disclosed
US-8039668-B2 Naphthalene-based inhibitors of anti-apoptotic proteins BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2011-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015992-A1 Napthalene-Based Inhibitors of Anti-Apoptotic Proteins HAX1, PRDX1, APOL1 RPS6KB1 4384/4885AURKA 3871/4885NR3C2 429/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.